Podcast Episodes

Back to Search
1.24 Useless Medical Conferences and Dr. Adam Obley on Vascepa, Fish Oil, Vitamin D and Methotrexate
1.24 Useless Medical Conferences and Dr. Adam Obley on Vascepa, Fish Oil, Vitamin D and Methotrexate

In this episode we discuss John Ioannidis' article on the uselessness of medical conferences, published in JAMA: "Are Medical Conferences Useful? And…

7 years, 9 months ago

Short Long
View Episode
1.23 BONUS! Developing Technology with Fewer Reversals: Maybe We Need More Translation Failure
1.23 BONUS! Developing Technology with Fewer Reversals: Maybe We Need More Translation Failure

This BONUS episode is the recording of a lecture given as part of the Biomedical Engineering Seminar series at Oregon Health & Science University on …

7 years, 9 months ago

Short Long
View Episode
1.22 Elo-Pom-Dex, Immunotherapy Combos, Inherent Bias, and the FDA with Dr. Erick Turner
1.22 Elo-Pom-Dex, Immunotherapy Combos, Inherent Bias, and the FDA with Dr. Erick Turner

In this episode, we tackle the recent papers in the New England Journal of Medicine on "Elotuzumab plus Pomalidomide and Dexamethasone for Multiple M…

7 years, 9 months ago

Short Long
View Episode
1.21 Nab-Paclitaxel in CCA, OS of PALOMA-3, Transparency, and Dr. Talal Hilal's Advice for Trainees
1.21 Nab-Paclitaxel in CCA, OS of PALOMA-3, Transparency, and Dr. Talal Hilal's Advice for Trainees

In this episode we question the conclusions of the phase II trial "Nab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic C…

7 years, 10 months ago

Short Long
View Episode
1.20 Precision Oncology: Some Benefit, Mostly Hype and Mentorship with Dr. Andrae Vandross
1.20 Precision Oncology: Some Benefit, Mostly Hype and Mentorship with Dr. Andrae Vandross

We begin this episode analyzing the unrepentant hype of precision oncology in a monologue that was originally one half of a debate titled: "Is Precis…

7 years, 10 months ago

Short Long
View Episode
1.19 BONUS! Introduction to Cancer Drug Policy
1.19 BONUS! Introduction to Cancer Drug Policy

This BONUS episode is the recording of a lecture given as part of a Cancer Intersession course for med students at Oregon Health & Science University…

7 years, 10 months ago

Short Long
View Episode
1.18 IMpassion130 and Hot-Spotting with Dr. Brian Chan
1.18 IMpassion130 and Hot-Spotting with Dr. Brian Chan

In this episode we evaluate the IMpassion130 trial on the use of atezolizumab in triple-negative breast cancer. We also interview Dr. Brian Chan of O…

7 years, 10 months ago

Short Long
View Episode
1.17 BONUS! Interpretation of Cancer Clinical Trials
1.17 BONUS! Interpretation of Cancer Clinical Trials

This BONUS episode is the recording of a two-part talk addressed to oncology fellows given at Oregon Health & Science University on October 5 and Oct…

7 years, 10 months ago

Short Long
View Episode
1.16 BONUS! Crowdsourcing Data Analysis and Medical Reversal: Why 40% of What We Do is Wrong
1.16 BONUS! Crowdsourcing Data Analysis and Medical Reversal: Why 40% of What We Do is Wrong

This BONUS episode is the recording of the Hospitalist Grand Rounds given at Oregon Health & Science University on October 11, 2018. The talk is on m…

7 years, 10 months ago

Short Long
View Episode
1.15 Minimally Effective Treatments, CheckMate 331, and Dr. Adam Obley on Low-Value Healthcare
1.15 Minimally Effective Treatments, CheckMate 331, and Dr. Adam Obley on Low-Value Healthcare

In this episode we review the recent paper in Nature Reviews Clinical Oncology by Booth, C.M. and Detsky, A.S. titled "Why patients receive treatment…

7 years, 10 months ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us